These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 24828968)

  • 1. Candidate metrics for evaluating the impact of prescriber education on the safe use of extended-release/long-acting (ER/LA) opioid analgesics.
    Willy ME; Graham DJ; Racoosin JA; Gill R; Kropp GF; Young J; Yang J; Choi J; MaCurdy TE; Worrall C; Kelman JA
    Pain Med; 2014 Sep; 15(9):1558-68. PubMed ID: 24828968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid tolerance and urine drug testing among initiates of extended-release or long-acting opioids in Food and Drug Administration's Sentinel System.
    Larochelle MR; Cocoros NM; Popovic J; Dee EC; Kornegay C; Ju J; Racoosin JA
    J Opioid Manag; 2017; 13(5):315-327. PubMed ID: 29199397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opioid prescribing in emergency departments: the prevalence of potentially inappropriate prescribing and misuse.
    Logan J; Liu Y; Paulozzi L; Zhang K; Jones C
    Med Care; 2013 Aug; 51(8):646-53. PubMed ID: 23632597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opioid prescribing practices in chronic pain management: guidelines do not sufficiently influence clinical practice.
    Victor TW; Alvarez NA; Gould E
    J Pain; 2009 Oct; 10(10):1051-7. PubMed ID: 19595639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the impact of the extended-release/long-acting opioid an-algesics risk evaluation and mitigation strategies on opioid prescrip-tion volume.
    Divino V; Cepeda MS; Coplan P; Maziere JY; Yuan Y; Wade RL
    J Opioid Manag; 2017; 13(3):157-168. PubMed ID: 28829517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of Potentially Inappropriate Prescribing of Opioid Analgesics Requiring Prior Opioid Tolerance.
    Jeffery MM; Chaisson CE; Hane C; Rumanes L; Tucker J; Hang L; McCoy R; Chen CL; Bicket MC; Hooten WM; Larochelle M; Becker WC; Kornegay C; Racoosin JA; Sanghavi D
    JAMA Netw Open; 2020 Apr; 3(4):e202875. PubMed ID: 32293684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of prescription opioids with abuse-deterrent technology to address opioid abuse.
    Michna E; Kirson NY; Shei A; Birnbaum HG; Ben-Joseph R
    Curr Med Res Opin; 2014 Aug; 30(8):1589-98. PubMed ID: 24738694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of opioid risk management and review of the classwide REMS for extended-release/long-acting opioids.
    Stanos S
    Phys Sportsmed; 2012 Nov; 40(4):12-20. PubMed ID: 23306411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Extended-Release/Long-Acting Opioid Prescribing Risk Evaluation and Mitigation Strategy Program by the US Food and Drug Administration: A Review.
    Heyward J; Olson L; Sharfstein JM; Stuart EA; Lurie P; Alexander GC
    JAMA Intern Med; 2020 Feb; 180(2):301-309. PubMed ID: 31886822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compliance with opioid treatment guidelines for chronic non-cancer pain (CNCP) in primary care at a Veterans Affairs Medical Center (VAMC).
    Sekhon R; Aminjavahery N; Davis CN; Roswarski MJ; Robinette C
    Pain Med; 2013 Oct; 14(10):1548-56. PubMed ID: 23746149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SCOPE of Pain: An Evaluation of an Opioid Risk Evaluation and Mitigation Strategy Continuing Education Program.
    Alford DP; Zisblatt L; Ng P; Hayes SM; Peloquin S; Hardesty I; White JL
    Pain Med; 2016 Jan; 17(1):52-63. PubMed ID: 26304703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid epidemic in the United States.
    Manchikanti L; Helm S; Fellows B; Janata JW; Pampati V; Grider JS; Boswell MV
    Pain Physician; 2012 Jul; 15(3 Suppl):ES9-38. PubMed ID: 22786464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical cost savings associated with an extended-release opioid with abuse-deterrent technology in the US.
    Rossiter LF; Kirson NY; Shei A; White AG; Birnbaum HG; Ben-Joseph R; Michna E
    J Med Econ; 2014 Apr; 17(4):279-87. PubMed ID: 24559196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between early opioid prescribing for acute occupational low back pain and disability duration, medical costs, subsequent surgery and late opioid use.
    Webster BS; Verma SK; Gatchel RJ
    Spine (Phila Pa 1976); 2007 Sep; 32(19):2127-32. PubMed ID: 17762815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential misuse and inappropriate prescription practices involving opioid analgesics.
    Liu Y; Logan JE; Paulozzi LJ; Zhang K; Jones CM
    Am J Manag Care; 2013 Aug; 19(8):648-658. PubMed ID: 24304213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States.
    Cicero TJ; Surratt H; Inciardi JA; Munoz A
    Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):827-40. PubMed ID: 17636553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter, 12-month, open-label, single-arm safety study of oxycodone-hydrochloride/naltrexone-hydrochloride extended-release capsules (ALO-02) in patients with moderate-to-severe chronic noncancer pain.
    Arora S; Setnik B; Michael D; Hudson JD; Clemmer R; Meisner P; Pixton GC; Goli V; Sommerville KW
    J Opioid Manag; 2014; 10(6):423-36. PubMed ID: 25531960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ER/LA opioid REMS and accredited education: Survey results provide insight into clinical roles, educational needs, and learner preferences.
    Kear C; McKeithen T; Robertson S
    Subst Abus; 2017; 38(2):145-149. PubMed ID: 28418777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of a reformulation of extended-release oxycodone designed to deter abuse in a sample of prescription opioid abusers.
    Havens JR; Leukefeld CG; DeVeaugh-Geiss AM; Coplan P; Chilcoat HD
    Drug Alcohol Depend; 2014 Jun; 139():9-17. PubMed ID: 24721614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A statewide prescription monitoring program affects emergency department prescribing behaviors.
    Baehren DF; Marco CA; Droz DE; Sinha S; Callan EM; Akpunonu P
    Ann Emerg Med; 2010 Jul; 56(1):19-23.e1-3. PubMed ID: 20045578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.